Table 1.
Aspirin |
Nonaspirin NSAIDs |
|||||||
---|---|---|---|---|---|---|---|---|
No use | ≤2 times/wk | >2–6 times/wk | Daily + | No use | ≤2 times/wk | >2–6 times/wk | Daily + | |
Cohort, n (%) | 80,879 (26.7) | 114,805 (38.0) | 28,891 (9.5) | 75,634 (25.0) | 130,928 (43.2) | 119,762 (39.6) | 18,311 (6.1) | 30,616 (10.1) |
Median age (interquartile range) | 63.5 (58.7–67.4) | 62.4 (57.8–66.7) | 63.5 (58.8–67.3) | 64.7 (60.2–68.0) | 64.5 (59.8–67.9) | 62.3 (57.6–66.6) | 62.4 (57.8–66.6) | 63.8 (59.1–67.5) |
Gender (% male) | 46.9 | 57.4 | 62.3 | 70.8 | 62.0 | 59.2 | 48.5 | 46.0 |
Race (% white) | 90.1 | 92.6 | 94.0 | 94.3 | 91.9 | 93.1 | 92.7 | 92.5 |
History of heart disease | 9.7 | 4.7 | 10.2 | 33.3 | 15.9 | 11.4 | 11.5 | 14.9 |